Operating Lease, Right-of-Use Asset of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. from 30 Dec 2018 to 27 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Dec 2018 to 27 Sep 2025.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Operating Lease, Right-of-Use Asset for the quarter ending 27 Sep 2025 was $374,273,000, a 2.8% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $374,273,000 -$10,860,000 -2.8% 27 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $385,756,000 -$391,000 -0.1% 28 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $402,908,000 +$18,514,000 +4.8% 29 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $412,490,000 +$18,461,000 +4.7% 28 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $385,133,000 +$9,811,000 +2.6% 28 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $386,147,000 -$11,045,000 -2.8% 29 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $384,394,000 -$24,070,000 -5.9% 30 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $394,029,000 +$2,267,000 +0.58% 30 Dec 2023 10-K 19 Feb 2025 2024 FY
Q3 2023 $375,322,000 +$1,912,000 +0.51% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $397,192,000 +$15,071,000 +3.9% 01 Jul 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $408,464,000 +$103,706,000 +34% 01 Apr 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $391,762,000 +$98,821,000 +34% 31 Dec 2022 10-K 14 Feb 2024 2023 FY
Q3 2022 $373,410,000 +$88,688,000 +31% 24 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $382,121,000 +$105,301,000 +38% 25 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $304,758,000 +$107,090,000 +54% 26 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $292,941,000 +$114,721,000 +64% 25 Dec 2021 10-K 22 Feb 2023 2022 FY
Q3 2021 $284,722,000 +$116,343,000 +69% 25 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $276,820,000 +$107,628,000 +64% 26 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $197,668,000 +$42,100,000 +27% 27 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $178,220,000 +$38,135,000 +27% 26 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $168,379,000 +$28,020,000 +20% 26 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $169,192,000 +$37,312,000 +28% 27 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $155,568,000 +$24,864,000 +19% 28 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $140,085,000 +$5,913,000 +4.4% 28 Dec 2019 10-K 17 Feb 2021 2020 FY
Q3 2019 $140,359,000 28 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $131,880,000 29 Jun 2019 10-Q 31 Jul 2019 2019 Q2
Q1 2019 $130,704,000 30 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $134,172,000 30 Dec 2018 10-K 11 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.